Susan D. Berland

Insider Reports History

Entity
Individual
Location
C/O Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco, California
Signature
/s/ Mike Rhee, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan D. Berland:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Senti Biosciences, Inc. Director Stock Option (Right to Buy) 62.5K Jun 16, 2023 Direct

Insider Reports Filed by Susan D. Berland

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNTI Senti Biosciences, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
SNTI Senti Biosciences, Inc. Jul 13, 2022 1 $0 4 Jul 15, 2022 Director
SNTI Senti Biosciences, Inc.\ Jun 8, 2022 0 $0 3 Jun 15, 2022 Director